18 Results for "

Tumor-homing peptides

" in MedChemExpress (MCE) Product Catalog:
Products (18)

18 Results for "Tumor-homing peptides" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-P2526
CAS No.: 454487-07-1
Target:  

Complement System

Research Areas:  

Cancer

LyP-1 is a cyclic 9-amino-acids tumor homing peptide and selectively bind to p32 receptors overexpressed in various tumor-associated cells .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P2526A
Target:  

Inhibitory Antibodies

Research Areas:  

Cancer

LyP-1 TFA is a cyclic 9 amino acids tumor homing peptide and selectively bind to p32 receptors overexpressed in various tumor-associated cells .
loading...
    loading...
Cat. No.: HY-142104
CAS No.: 934816-82-7
Synonyms: 2-Chlorotrityl Chloride Resin (100-200 mesh,1% DVB,0.4-3.0mmol/g)
Target:  

Drug Intermediate

Research Areas:  

Cancer

2-CTC Resin (100-200 mesh,1% DVB,0.4-3.0mmol/g) is a solid-phase synthesis carrier that has been used to study metabolic disorders in prostate cancer cells. 2-CTC Resin (100-200 mesh,1% DVB,0.4-3.0mmol/g) can be used as a reaction solution of terminal residues and adenine nucleotides to form cyclic peptides. 2-CTC Resin (100-200 mesh,1% DVB,0.4-3.0mmol/g) can prevent racemization during the incorporation of the first protected amino acid and minimized diketopiperazine formation. 2-CTC Resin (100-200 mesh,1% DVB,0.4-3.0mmol/g) is one of the most commonly used and versatile resins available for large-scale production of peptides .
loading...
    loading...
Cat. No.: HY-P10894
CAS No.: 2283322-63-2
Research Areas:  

Cancer

mUNO is a tumor-homing peptide (mUNO, sequence: "CSPGAK") that specifically binds to mouse CD206, targeting tumor-associated macrophages that express CD206/MRC1. mUNO can interact with human recombinant CD206 .
loading...
    loading...
Cat. No.: HY-172271
Target:  

Liposome

Research Areas:  

Cancer

DSPE-PEG1000-Mal-Cys-CGNKRTRGC (Disulfide bridge: Cys2-Cys10) is a PEG compound which composed of DSPE and a nine residue peptide (LyP-1) (HY-P2526). LyP-1 is a cyclic 9-amino-acids tumor homing peptide and selectively bind to p32 receptors overexpressed in various tumor-associated cells .
loading...
    loading...
Cat. No.: HY-P4089
CAS No.: 945245-82-9
Target:  

Inhibitory Antibodies

Research Areas:  

Cancer

REA is a homing peptide that targets pre-cancerous tumor lymphatic vessels. REA homes to lymphatic vessels at the pre-cancerous tumor stage, but does not recognize tumor lymphatic vessels. REA can be used in pre-cancerous tumor research .
loading...
    loading...
Cat. No.: HY-172271A
Target:  

Liposome

Research Areas:  

Cancer

DSPE-PEG2000-LyP-1 is a PEG compound which composed of DSPE and a nine residue peptide (LyP-1) (HY-P2526). LyP-1 is a cyclic 9-amino-acids tumor homing peptide and selectively bind to p32 receptors overexpressed in various tumor-associated cells .
loading...
    loading...
Cat. No.: HY-172271B
Target:  

Liposome

Research Areas:  

Cancer

DSPE-PEG3000-LyP-1 is a PEG compound which composed of DSPE and a nine residue peptide (LyP-1) (HY-P2526). LyP-1 is a cyclic 9-amino-acids tumor homing peptide and selectively bind to p32 receptors overexpressed in various tumor-associated cells .
loading...
    loading...
Cat. No.: HY-P11415
CAS No.: 1189359-89-4
Target:  

Inhibitory Antibodies

Research Areas:  

Cancer

GX1 is a tumor-homing peptide, and its amino acid sequence is CGNSNPKSC. GX1 can specifically target the vascular endothelial cells of gastric cancer and can be used as a specific imaging probe for gastric cancer angiogenesis .
loading...
    loading...
Cat. No.: HY-187402A
Research Areas:  

Cancer

DOPE-PEG2000-CSTSMLKAC is an amphiphilic lipid-PEG-peptide conjugate composed of DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine), PEG2000, and the CSTSMLKAC peptide, a cyclic tumor-homing peptide with a disulfide bond formed by flanking cysteine residues. DOPE-PEG2000-CSTSMLKAC is used for tumor-targeted drug delivery through liposome and nanoparticle surface modification.
loading...
    loading...
Cat. No.: HY-187410A
Synonyms: DOPE-PEG2000-Mal-Cys-APRPG
Research Areas:  

Cancer

DOPE-PEG2000-APRPG (DOPE-PEG2000-Mal-Cys-APRPG) is an amphiphilic lipid-PEG-peptide conjugate consisting of DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine), PEG2000, and the APRPG peptide (Ala-Pro-Arg-Gly), a tumor-homing peptide. DOPE-PEG2000-APRPG is used for tumor vasculature-targeted drug delivery.
loading...
    loading...
Cat. No.: HY-187416A
Synonyms: DOPE-PEG2000-Mal-Cys-CGKRK
Research Areas:  

Cancer

DOPE-PEG2000-CGKRK (DOPE-PEG2000-Mal-Cys-CGKRK) is an amphiphilic lipid-PEG-peptide conjugate consisting of DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine), PEG2000, and the CGKRK peptide, a tumor-homing peptide identified by in vivo phage display. DOPE-PEG2000-CGKRK is used for tumor-targeted drug delivery through liposome and nanoparticle surface modification.
loading...
    loading...
Cat. No.: HY-187490A
Synonyms: DOPE-PEG2000-Mal-Cys-CREKA
Research Areas:  

Cancer

DOPE-PEG2000-CREKA (DOPE-PEG2000-Mal-Cys-CREKA) is an amphiphilic lipid-PEG-peptide conjugate consisting of DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine), PEG2000, and the CREKA peptide (Cys-Arg-Glu-Lys-Ala), a tumor-homing peptide identified by in vivo phage display. DOPE-PEG2000-CREKA is used for tumor stroma-targeted drug delivery.
loading...
    loading...
Cat. No.: HY-P11815
CAS No.: 1227627-77-1
Target:  

Inhibitory Antibodies

Research Areas:  

Cancer

TMTP1 is a five-amino acid (NVVRQ) tumor-homing peptide. TMTP1 slows the growth of tumor cells. TMTP1 serves as a diagnostic marker for hematological malignancies and acts as an anticancer drug carrier to enhance the cellular uptake rate of nanocarriers in tumor tissues. TMTP1 is applicable to research related to hematological malignancies, lymphoma, chronic myeloid leukemia, cervical cancer, and ovarian cancer .
loading...
    loading...
Cat. No.: HY-187401A
Synonyms: DOPE-PEG2000-Mal-Cys-KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK
Research Areas:  

Cancer

DOPE-PEG2000-F3 (DOPE-PEG2000-Mal-Cys-KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK) is an amphiphilic lipid-PEG-peptide conjugate composed of DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine), PEG2000, and the F3 peptide, a tumor-homing peptide derived from the high-mobility group protein N2 (HMGN2). DOPE-PEG2000-F3 is used for tumor-targeted drug delivery.
loading...
    loading...
Cat. No.: HY-187474A
Synonyms: DOPE-PEG2000-Mal-Cys-HTMYYHHYQHHL
Research Areas:  

Cancer

DOPE-PEG2000-K237 (DOPE-PEG2000-Mal-Cys-HTMYYHHYQHHL) is an amphiphilic lipid-PEG-peptide conjugate composed of DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine), PEG2000, and the K237 peptide (sequence: HTMYYHHYQHHL). K237 peptide is a tumor-homing peptide identified by phage display that specifically binds to vasculature in tumor tissues. DOPE-PEG2000-K237 is used for tumor-targeted drug delivery via functionalization of liposomes and nanoparticles.
loading...
    loading...
Cat. No.: HY-187399A
Synonyms: DOPE-PEG2000-Mal-Cys-NGR
Research Areas:  

Cancer

DOPE-PEG2000-NGR (DOPE-PEG2000-Mal-Cys-NGR) is an amphiphilic lipid-PEG-peptide conjugate composed of DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine), PEG2000, and the NGR (Asn-Gly-Arg) peptide, a tumor-homing tripeptide motif. NGR peptide specifically binds to aminopeptidase N (CD13) that is overexpressed on angiogenic tumor vasculature. DOPE-PEG2000-NGR is used for tumor vasculature-targeted drug delivery and anti-angiogenic research.
loading...
    loading...
Cat. No.: HY-P11816
Research Areas:  

Cancer

DOTA-cTMTP1 is a cyclic tumor-homing peptide precursor molecule. DOTA-cTMTP1 selectively binds to XPNPEP2 on highly metastatic tumor cells, accumulates and retains in hepatocellular carcinoma tumors, and maintains a high tumor-to-liver contrast over time in small animal models. After radiolabeling with 68Ga, DOTA-cTMTP1 forms a PET probe for positron emission tomography (PET) imaging of hepatocellular carcinoma (HCC).
loading...
    loading...
  • 1